Results 141 to 150 of about 14,659,030 (367)
Design of self-checking software [PDF]
, 1975 Stephen S. Yau, Ray C. C. Cheung
openalex +2 more sources
Molecular Oncology, EarlyView.The COMBAT classification system, developed through multi‐omics integration, stratifies adult patients with B‐cell acute lymphoblastic leukemia(B‐ALL) into three molecular subtypes with distinct surface antigen patterns, immune landscape, methylation patterns, biological pathways and prognosis.
Yang Song +11 more
wiley +1 more source
The REDCap consortium: Building an international community of software platform partners
Journal of Biomedical Informatics, 2019 P. Harris +10 more
semanticscholar +1 more source
Molecular Oncology, EarlyView.In patients treated with atezolizumab as a part of the MyPathway (NCT02091141) trial, pre‐treatment ctDNA tumor fraction at high levels was associated with poor outcomes (radiographic response, progression‐free survival, and overall survival) but better sensitivity for blood tumor mutational burden (bTMB).
Charles Swanton +17 more
wiley +1 more source
Improving of the Test Conditions of Passenger Tires with the Help of Software Written on Delphi
Механика машин, механизмов и материалов, 2015 A modernization of the test tire was held with software that allows to improve the test procedures of passenger car tires in a wide range and save energy.
Sergei I. Medveditskov +2 more
doaj
Molecular Oncology, EarlyView.Non‐thermal plasma treatment of melanoma cells induced epithelial‐mesenchymal transition (EMT) in a dose‐dependent fashion. This report highlights the critical need to further investigate potential adverse effects of non‐thermal plasma for cancer therapy and to optimize treatment parameters for clinical translation. Despite the promising results of non‐
Eline Biscop +10 more
wiley +1 more source
Revista Latino-Americana de EnfermagemEsta pesquisa tem por objetivo elaborar um software sobre diabetes mellitus para dar subsídios à educação continuada dos profissionais de saúde e suas práticas educativas.
Erika Christiane Marocco Duran +1 more
doaj
Molecular Oncology, EarlyView.Trastuzumab‐deruxtecan, a HER2‐targeting antibody‐drug conjugate, shows promising antitumor activity in head and neck squamous cell carcinoma with low HER2 expression. In vitro and in vivo studies demonstrated dose‐dependent cell death and tumor growth reduction in low HER2‐expressing cell lines, which correlated with drug accumulation measured using a
Abdullah Bin Naveed +8 more
wiley +1 more source